Cardiovascular safety of COX-2 inhibition: Time to inform systems of postmarketing surveillance?

Robert J. MacFadyen, Thomas M. MacDonald

    Research output: Contribution to journalEditorial

    86 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)325-328
    Number of pages4
    JournalTherapy
    Volume2
    Issue number3
    Publication statusPublished - May 2005

    Cite this